Euroapi is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world.  

We are a world leader in active pharmaceutical ingredients with some 200 products in our portfolio, offering a large span of technologies, while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO). 

The Group develops, manufactures, markets and distributes active pharmaceutical ingredients (APIs) and intermediates used in the formulation of medicines for human and veterinary use, both from originators and generics, including all types of molecules in the API market: small molecules (including complex chemical synthesis molecules, biochemistry molecules derived from fermentation and highly potent molecules (“HP-APIs”)) and large molecules (such as peptides and oligonucleotides). 

With strong research and development capabilities and six manufacturing sites all located in Europe, Euroapi ensures API manufacturing of the highest quality to supply customers in more than 80 countries. 

Find out more at We look forward to meeting you in Philadelphia! 

Feel free to schedule a meeting with us at CPhI North America: